Skeletal muscle mitochondrial dysfunction & diabetes

Indian Journal of Medical Research

Volumn 125, Issue 3, 2007, Pages 399-410

  Sreekumar, Raghavakaimal ^a   Nair, K Sreekumaran ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diabetes; Lipid peroxides; Mitochondrial dysfunction; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; GENE PRODUCT; GLUCOSE; INSULIN; LIPID PEROXIDE; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; PROTEIN OXPHOS; UNCLASSIFIED DRUG;

AGING; BIOGENESIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; MICROARRAY ANALYSIS; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OXIDATIVE PHOSPHORYLATION;

EID: 34249282715     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. Zimmet PZ, McCarty DJ, De Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 1997; 11: 60-8.
3. Huizinge MM, Rothman RL. Addressing the diabetic pandemic: A comprehensive approach. Indian J Med Res 2006; 124: 481-4.
4. Mohan V, Sandeep S, Deepa R, Shah B, Verghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007; 125: 217-30.
5. Abate N, Chandalia M. Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001; 15: 320-7.
6. Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease- the Chennai Urban Population Study (CUPS no. 15). Diab Med 2005; 22: 1206-11.
7. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22: 241-7.
8. Fujimoto WY. Diabetes in Asian and Pacific Islander Americans. In: Diabetes in America. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995 p. 661-82.
9. McCarthy MI, Hitman GA, Morton NE, Snehalatha C, Mohan V, Ramachandran A, et al. Family studies of non-insulin-dependent diabetes mellitus in South Indians. Diabetologia 1994; 37: 1221-30.
10. Ramachandran A, Snehalatha C, Viswanathan V. Burden of type 2 diabetes and its complications - The Indian scenario. Curr Sci 2002; 83: 1471-6.
11. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44: 1094-101.
12. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care 2003; 26: 1022-5.
13. Ramachandran A. Epidemiology of type 2 diabetes in Indians. J Indian Med Assoc 2002; 100: 425-7.
14. Raman Kutty V, Joseph A, Soman CR. High prevalence of type 2 diabetes in an urban settlement in Kerala, India. Ethn Health 1999; 4: 231-9.
15. Mohan V, Shanthirani CS, Deepa R. Glucose intolerance (Diabetes and IGT) in a selected south Indian population with special reference to family history, obesity and lifestyle factors - the Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 2003; 51: 771-7.
16. Short KR, Vittone J, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52: 1888-96.
17. Nair KS. Aging muscle: What causes it? E.V. McCollum Lecture 2004. Am J Clin Nutr 2005; 81: 953-63.
18. Eriksson J, Franssila-Kallunki A, Ekstrand AV, Saloranta C, Widen E, Schalin C, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-43.
19. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-68.
20. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-50.
21. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002; 51: 1913-20.
22. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J, et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-73.
23. Stump CS, Short KR, Bigelow ML, Schimke JC, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003; 100: 7996-8001.
24. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-71.
25. Petersen KF, Befroy D, Sufour S, Dziura J, Ariyan C, Rothman DL, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300: 1140-2.
26. Short KR, Bigelow ML, Kahl JC, Singh R, Coenen-Schimke JM, Raghavakaimal S, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA 2005; 102: 5618-23.
27. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005; 54: 8-14.
28. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 2006; 119: S10-6.
29. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic beta-cells. Nature 2001; 414: 807-12.
30. Short KR, Nair KS, Stump CS. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 2419-21.
31. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 1999; 286: 774-9.
32. Barazzoni R, Short KR, Nair KS. Effects of aging on mitochondrial DNA copy number and cytochrome C oxidase gene expression in rat skeletal muscle, liver, and heart. J Biol Chem 2000; 275: 3343-7.
33. Rooyackers OE, Adey DB, Ades PA, Nair KS. Effect of age in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA 1996; 93: 15364-9.
34. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52: 1-8.
35. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-90.
36. Lamson DW, Plaza SM. Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment. Altern Med Rev 2002; 7: 94-111
37. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-23.
38. Maassen JA. Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Genetics 2002; 115: 66-70.
39. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res 1999; 31: 261-72.
40. Bayraktutan U. Free radicals, diabetes and endothelial dysfunction. Diabetes Obes Metab 2002; 4: 224-38.
41. Inoguchi T, Li P, Umeda F, Yan Yu H, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-45.
42. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001; 280: E685-94.
43. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88: E14-22.
44. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep 2000; 2: 167-73.
45. Hamilton CA, Brosnan MJ, Al Benna S, Berg G, Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002; 40: 755-62.
46. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002; 51: 1118-24.
47. Huynh NT, Tayek JA. Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation. J Am Coll Nutr 2002; 21: 422-7.
48. Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 1997; 29: 8-15.
49. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol 2001; 281: H981-6.
50. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20.
51. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic Res 2003; 37: 33-40.
52. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997; 416: 15-8.
53. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001; 108: 1341-8.
54. Schalch DS, Kipnis DM. Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 1965; 44: 2010-20.
55. Gollnick PD, Armstrong RB, Saubert CW IV, Piehl K, Saltin BX. Enzyme activity and fiber composition in skeletal muscel of untrained and trained men. J Appl Physiol 1972; 33: 312-9.
56. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes 1999; 48: 1600-6.
57. Ho JK, Duclos RI Jr, Hamilton JA. Interactions of acyl carnitines with model membranes: a (13)C-NMR study. J Lipid Res 2002; 43: 1429-39.
58. Echtay KS, Esteves TC, Pakay JL, Jekabsons MB, Lambert AJ, Portero-Otin M, et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 2003; 22: 4103-10.
59. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, Ido Y, et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000; 275: 16258-66.
60. Brand MD, Pamplona R, Portero-Otin M, Requena JR, Roebuck SJ, Buckingham JA, et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 2002; 368: 597-603.
61. Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Deriaz O, et al. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 2003; 551: 104-6.
62. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002; 418: 797-801.
63. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type I (insulin-dependent) diabetic patients. Diabetologia 1984; 27: 13-6.
64. Nair KS, Halliday D. Energy and protein metabolism in diabetes and obesity. In: Garrow JS, Halliday D, editors. Substrate and energy metabolism in man. London: John Libbey; 1985 p. 195-202.
65. Charlton MR, Nair KS. Role of hyperglucagonemia in catabolism associated with type 1 diabetes. Effects on leucine metabolism and the resting metabolic rate. Diabetes 1998; 47: 1748-56.
66. Nair KS, Webster J, Garrow JS. Effect of impaired glucose tolerance and type II diabetes mellitus on resting metabolic rate and thermic response to a glucose meal in obesity women. Metabolism 1986; 35: 640-4.
67. Bogardus C, Taskinen MR, Zawadzki JK, Lillioja S, Mott D, Howard BV. Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 1986; 35: 1-5.
68. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983; 25: 400-3.
69. Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, Wahren J. Protein dynamics in whole body and in splachnic and leg tissues in type I diabetic patients. J Clin Invest 1995; 95: 2926-37.
70. Berdanier CD. Mitochondrial gene expression in diabetes mellitus: effect of nutrition. Nutr Rev 2001; 59: 61-70.
71. Ballinger SW. Maternally transmitted diabetes and deafness associated with a 10.4 Kb mitochondrial DNA deletion. Nat Genet 1992; 1: 11-5.
72. Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995; 1271: 253-60.
73. Olsson C, Zethelius B, Lagerstrom-Fermer M, Asplund J, Berne C, Landegren U. Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum Mutat 1998: 12: 52-8.
74. Thomas AW, Edwards A, Sherratt EJ, Majid A, Gagg J, Alcolado JC. Molecular scanning of candidate mitochondrial tRNA genes in type 2 (non-insulin dependent) diabetes mellitus. J Med Genetics 1996; 33: 253-5.
75. Serradas P, Giroix MH, Saulnier C, Gangnerau MN, Borg LA, Welsh M, et al. Mitochondrial deoxyribonucleic acid content is specifically decreased in adult, but not fetal, pancreatic islets of the Goto-Kakizaki rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 1995; 136: 5623-31.
76. Jang YY, Song JH, Shin YK, Han ES, Lee CS. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000; 42: 361-71.
77. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466-71.
78. Carvalho E, Jansson PA, Axelsen M, Ericksson JW, Huang X, Groop LC, et al. Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J 1999; 13: 2173-8.
79. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 1990; 85: 522-9.
80. Krook A, Digby J, O'Rahilly S, Zierath JR, Wallberg-Henriksson H. Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes 1998; 47: 1528-31.
81. Choi WH, O'Rahilly S, Buse JB, Rees A, Morgan R, Flier JS, et al. Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 1991; 40: 1712-8.
82. Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, et al. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 1998; 47: 387-94.
83. Cusi K, Maezono K, Osman AA, Pendergrass M, Patti ME, Pratipanawatr T, et al. Insulin resistance differentially affects the PI3-kinase-and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-20.
84. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 1998; 47: 1281-6.
85. Reynet C, Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993; 262: 1441-4.
86. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain 10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-75.
87. Permutt MA, Bernal-Mizrachi E, Inoue H. Calpain 10: the first positional cloning of a gene for type 2 diabetes? J Clin Invest 2000; 106: 819-21.
88. Choi YS, Kim S, Pak YK. Mitochondrial transcription factor A (mtTFA) and diabetes. Diabetes Res Clin Pract 2001; 54: S3-9.
89. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003; 24: 78-90.
90. Attie AD, Kendziorski CM. PGC-1alpha at the crossroads of type 2 diabetes. Nat Genet 2003; 34: 244-5.
91. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AD, Andres R. Age as independent determinant of glucose tolerance. Diabetes 1991; 40: 44-51.
92. Houmard JA, Weidner MD, Dolan PL, Leggett-Frazier N, Gavigan KE, Hickey MS, et al. Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 1995; 44: 555-60.
93. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 2001; 50: 2652-8.
94. Huang X, Eriksson K-F, Vaag A, Lehtovirta M, Hansson M, Laurila E, et al. Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes 1999; 48: 1508-14.
95. Kruszynska YT, Mulford MI, Baloga J, Yu JG, Olefsky JM. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Diabetes 1998; 47: 1107-13.
96. Vondra K, Rath R, Bass A, Slabochova Z, Temparis S, Vitek V. Enzyme activities in quadriceps femoris muscle of obese diabetic male patients. Diabetologia 1977; 13: 527-9.
97. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997; 83: 166-71.
98. Halvatsiotis P, Short KR, Bigelow ML, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002; 51: 2395-404.